Skip to content
Alkermes logo

Alkermes Alternatives & Competitors

12 companies similar to Alkermes — Alkermes is a global biopharmaceutical company that seeks to develop innovative...

Companies similar to Alkermes

Lyndra Therapeutics logo — alternative to Alkermes

Lyndra Therapeutics

What if we stopped trying to change the patient and changed the pill instead?

UCB logo — alternative to Alkermes

UCB

We’re #TeamUCB, a global biopharmaceutical company. 💙 Inspired by patients 🔬 Driven by s...

MODAVAR PHARMACEUTICALS LLC logo — alternative to Alkermes

MODAVAR PHARMACEUTICALS LLC

A global pharmaceutical company with a mission to reimagine medicines that enhance and ext...

Praxis Precision Medicines, Inc. logo — alternative to Alkermes

Praxis Precision Medicines, Inc.

The era of genetic neuroscience has arrived

Rival Readout

Competing with Alkermes? We do this properly.

10 rivals, 90 days of dated moves, ranked by what matters and sourced, in 7 business days.

Book a 7-day Readout
Engrail Therapeutics logo — alternative to Alkermes

Engrail Therapeutics

Transforming the lives of patients with life-limiting diseases of the nervous system

Acadia Pharmaceuticals logo — alternative to Alkermes

Acadia Pharmaceuticals

Acadia is trailblazing breakthroughs in neuroscience to elevate life.

PsychoGenics logo — alternative to Alkermes

PsychoGenics

Discover Your Next Breakthrough

Vistagen logo — alternative to Alkermes

Vistagen

Changing the trajectory of mental health care – One Mind at a Time

Newron Pharmaceuticals SpA logo — alternative to Alkermes

Newron Pharmaceuticals SpA

The Specialist in CNS Drug Development

Biogen logo — alternative to Alkermes

Biogen

Innovative therapies worldwide for people living with serious neurological and neurodegene...

Euthymics Bioscience logo — alternative to Alkermes

Euthymics Bioscience

Developing next-gen treatments for depression targeting those unmet by SSRIs

PaxMedica, Inc. logo — alternative to Alkermes

PaxMedica, Inc.

Empowering Possibilities, Transforming Lives: PaxMedica's Journey in Neurodevelopmental So...

About Alkermes

Alkermes is a global biopharmaceutical company, founded in 1987, focused on developing innovative medicines for neuroscience. The company's portfolio includes commercial products for alcohol dependence, opioid dependence, schizophrenia, and bipolar I disorder, as well as a pipeline of candidates for neurological disord...

Business keywords

Biopharmaceutical, Neuroscience, Medicines, Psychiatric Disorders, Neurological Disorders, Alcohol Dependence, Opioid Dependence, Schizophrenia, Bipolar I Disorder, Clinical Research, Preclinical Research, Patient-Centered, Global Operations, R&D Center, Manufacturing Facilities

Frequently Asked Questions

Companies similar to Alkermes include Lyndra Therapeutics, UCB, MODAVAR PHARMACEUTICALS LLC, Praxis Precision Medicines, Inc., Engrail Therapeutics. They work in Biotechnology and Health Care and share Alkermes's focus on neurological disorders, biopharmaceutical and neuroscience.
Bounce Watch lists 12 companies that share Alkermes's industries and are closest to it in business tags, services, target customers, business model and size.
Alkermes is a global biopharmaceutical company, founded in 1987, focused on developing innovative medicines for neuroscience. The company's portfolio includes commercial products for alcohol dependence, opioid dependence, schizophrenia, and bipolar I disorder, as well as a pipeline of candidates for neurological disord...

From the desk

Mapping a market? Start with a Rival Readout.

In 7 business days we read 10 rivals around Alkermes: 90 days of dated moves, ranked by what matters to you, each with its source. Fully credited if you continue.

Compiled from the BounceWatch company index. We last looked at Alkermes on 9 Jun 2026. The 12 companies listed here were last checked between 11 Sep 2024 and 23 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout